BioSpace News Archive

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, announced that on February 17, 2022, the Company approved the grant of inducement stock options covering an aggregate of 138,575 shares of Iovance’s common stock to nineteen new non-executive employees.

Ocugen, Inc. (NASDAQ: OCGN), announced that the U.S. Food and Drug Administration (FDA) has lifted its clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as COVAXIN™ outside the United States.

The U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use.

Keeping in mind the development of the healthcare sector across both developed as well as developing countries, the global oscillating positive expiratory pressure devices market is expected to witness a steady growth in the coming years of the forecast period.

Needlesticks have been key cause of sharps injuries to healthcare workers and consequently exposing them to blood-borne pathogens.

Non-steroidal anti-inflammatory drugs is a class of powerful analgesics, distinguished by their non-steroidal chemical structure.

Diabetes is a metabolic disease, wherein the body is either unable to secret insulin or is unable to utilize the generated insulin.

Innovations in advanced wound care dressings have changed the paradigm of health care standards since the last decade.

Metabolism is a process through which food is broken-down into sugars and acids in the body.

Incidence of hearing loss is a massive burden on healthcare and governments.